Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Steqeyma® (ustekinumab-stba) – New biosimilar approval

December 18, 2024 - Celltrion announced the FDA approval of Steqeyma (ustekinumab-stba), the 7th biosimilar to Janssen’s Stelara® (ustekinumab).

Download PDF

Rx navigation